Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8 + lymphocytes in primary sarcomas is subtype dependent
van Erp, Anke E M, Versleijen-Jonkers, Yvonne M H, Hillebrandt-Roeffen, Melissa H S, van Houdt, Laurens, Gorris, Mark A J, van Dam, Laura S, Mentzel, Thomas, Weidema, Marije E, Savci-Heijink, C Dilara, Desar, Ingrid M E, Merks, Hans H M, van Noesel, Max M, Shipley, Janet, van der Graaf, Winette T A, Flucke, Uta E, Meyer-Wentrup, Friederike A G
Published in Oncotarget (19.09.2017)
Published in Oncotarget (19.09.2017)
Get full text
Journal Article
Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo
van Erp, Anke E. M., van Houdt, Laurens, Hillebrandt-Roeffen, Melissa H. S., van Bree, Niek F. H. N., Flucke, Uta E., Mentzel, Thomas, Shipley, Janet, Desar, Ingrid M. E., Fleuren, Emmy D. G., Versleijen-Jonkers, Yvonne M. H., van der Graaf, Winette T. A.
Published in Journal of cancer research and clinical oncology (01.07.2020)
Published in Journal of cancer research and clinical oncology (01.07.2020)
Get full text
Journal Article
Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes
van der Steen, Sophieke C.H.A., Raavé, René, Langerak, Sjoerd, van Houdt, Laurens, van Duijnhoven, Sander M.J., van Lith, Sanne A.M., Massuger, Leon F.A.G., Daamen, Willeke F., Leenders, William P., van Kuppevelt, Toin H.
Published in European journal of pharmaceutics and biopharmaceutics (01.04.2017)
Published in European journal of pharmaceutics and biopharmaceutics (01.04.2017)
Get full text
Journal Article
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
van Erp, Anke E. M., Hillebrandt-Roeffen, Melissa H. S., van Houdt, Laurens, Fleuren, Emmy D. G., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
Published in Targeted oncology (01.12.2017)
Published in Targeted oncology (01.12.2017)
Get full text
Journal Article
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
Fleuren, Emmy D G, Vlenterie, Myrella, van der Graaf, Winette T A, Hillebrandt-Roeffen, Melissa H S, Blackburn, James, Ma, Xiuquan, Chan, Howard, Magias, Mandy C, van Erp, Anke, van Houdt, Laurens, Cebeci, Sabri A S, van de Ven, Amy, Flucke, Uta E, Heyer, Erin E, Thomas, David M, Lord, Christopher J, Marini, Kieren D, Vaghjiani, Vijesh, Mercer, Tim R, Cain, Jason E, Wu, Jianmin, Versleijen-Jonkers, Yvonne M H, Daly, Roger J
Published in Cancer research (Chicago, Ill.) (15.08.2017)
Published in Cancer research (Chicago, Ill.) (15.08.2017)
Get full text
Journal Article